Melio

melio.es ↗ ·Madrid ·Seed
Closed in 2024. Melio no longer appears in the directory or on the maps; its funding history is kept below. Source ↗

Melio was a Madrid-based healthtech company that sold blood tests directly to consumers through an online platform. Customers could order tests without a prescription and got results within 48 hours, with comments from a medical team. It offered more than ten test profiles covering over 100 health markers, such as hormones, cholesterol, glucose, PSA and iron, and it also sold Covid-19 PCR tests to travellers through UK high-street pharmacies. Its laboratory partner was Unilabs. The company was founded in the United Kingdom in March 2019 and launched in Madrid in October 2019. It operated in UK cities including London, Manchester, Bristol and Cambridge, and in Spain it expanded from Madrid and Barcelona to Valencia, Seville, Bilbao, Málaga, Zaragoza and other cities. Melio raised a €600,000 seed round led by UK healthcare and consumer investors, including Oxford-based Beaumont Capital and angel investor Gi Fernando. The service shut down on 31 March 2024.

Founded
2019
Founders
3
Total funds raised
€600K
Rounds
1
Investors
2
Last round
Feb 2020
SectorsHealthtech, Diagnostics, Consumer Health, Digital Health

Suggest a correction

Founders

Kai Xie
Co-founder & Head of Product
Mario Cantero
Co-founder & CEO
William Stoddart
Co-founder

Global models

No comparables on record yet.

In the same niche 49 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 2

Beaumont Capital
Seed 2020 HQ unknown
Gi Fernando
Seed 2020 United Kingdom

Funding rounds 1

DateRoundAmountLead

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list